UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 119

Sortiert nach

Primary myelofibrosis in untreated sickle cell disease: Are adult patients at higher risk for developing hematological myeloid neoplasms?

American journal of hematology, 2022-01, Vol.97 (1), p.4-6

Ribeil, Jean‐Antoine

2022

Volltextzugriff (PDF)

Gene Therapy in a Patient with Sickle Cell Disease

The New England journal of medicine, 2017-03, Vol.376 (9), p.848-855

2017

Volltextzugriff (PDF)

Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease

The New England journal of medicine, 2022-02, Vol.386 (7), p.617-628

2022

Volltextzugriff (PDF)

An integrated therapeutic approach to sickle cell disease management beyond infancy

American journal of hematology, 2023-07, Vol.98 (7), p.1087-1096

2023

Volltextzugriff (PDF)

Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene

Human gene therapy, 2016-02, Vol.27 (2), p.148

2016

Volltextzugriff (PDF)

Lovo‐cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB‐206 study

American journal of hematology, 2023-01, Vol.98 (1), p.11-22

2023

Volltextzugriff (PDF)

Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trial

Nature medicine, 2022-01, Vol.28 (1), p.81-88

2022

Volltextzugriff (PDF)

Safety and feasibility of hematopoietic progenitor stem cell collection by mobilization with plerixafor followed by apheresis vs bone marrow harvest in patients with sickle cell disease in the multi‐center HGB‐206 trial

American journal of hematology, 2020-09, Vol.95 (9), p.E239-E242

2020

Volltextzugriff (PDF)

Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion

Haematologica (Roma), 2018-05, Vol.103 (5), p.778

2018

Volltextzugriff (PDF)

Sotatercept, a novel transforming growth factor β ligand trap, improves anemia in β-thalassemia: a phase II, open-label, dose-finding study

Haematologica (Roma), 2019-03, Vol.104 (3), p.477

2019

Volltextzugriff (PDF)

Proliferating cell nuclear antigen acts as a cytoplasmic platform controlling human neutrophil survival

The Journal of experimental medicine, 2010-11, Vol.207 (12), p.2631-2645

2010

Volltextzugriff (PDF)

A novel, highly potent and selective phosphodiesterase-9 inhibitor for the treatment of sickle cell disease

Haematologica (Roma), 2020-03, Vol.105 (3), p.623

2020

Volltextzugriff (PDF)

Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome

PloS one, 2017-03, Vol.12 (3), p.e0172147

2017

Volltextzugriff (PDF)

Ineffective Erythropoiesis in β-Thalassemia

TheScientificWorld, 2013-01, Vol.2013 (1), p.394295-394295

2013

Volltextzugriff (PDF)

A biomimetic microfluidic chip to study the circulation and mechanical retention of red blood cells in the spleen

American journal of hematology, 2015-04, Vol.90 (4), p.339-345

2015

Volltextzugriff (PDF)

Pregnancy outcome in women with transfused beta-thalassemia in France

Annals of hematology, 2022-02, Vol.101 (2), p.289-296

2022

Volltextzugriff (PDF)

Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1

Nature, 2007-01, Vol.445 (7123), p.102-105

2007

Volltextzugriff (PDF)

Cytoplasmic proliferating cell nuclear antigen connects glycolysis and cell survival in acute myeloid leukemia

Scientific reports, 2016-10, Vol.6 (1), p.35561-35561, Article 35561

2016

Volltextzugriff (PDF)

Roles of APOL1 G1 and G2 variants in sickle cell disease patients: kidney is the main target

British journal of haematology, 2017-10, Vol.179 (2), p.323-335

2017

Volltextzugriff (PDF)

Carboxy-terminal fragment of fibroblast growth factor 23 induces heart hypertrophy in sickle cell disease

Haematologica (Roma), 2017-02, Vol.102 (2), p.e33

2017

Volltextzugriff (PDF)

Arterio‐venous fistula for automated red blood cells exchange in patients with sickle cell disease: Complications and outcomes

American journal of hematology, 2017-02, Vol.92 (2), p.136-140

2017

Volltextzugriff (PDF)

Gene-addition/editing therapy in sickle cell disease

La Presse médicale (1983), 2023-12, Vol.52 (4), p.104214-104214, Article 104214

2023

Volltextzugriff (PDF)

S274: A NEW, EFFECTIVE, SAFE, NON‐MYELOABLATIVE CONDITIONING REGIMEN WITH A HLA‐MATCHED SIBLING DONOR FOR THE SEVERE SICKLE CELL PHENOTYPE IN ADULTS

HemaSphere, 2023-08, Vol.7 (S3), p.e75086e6-n/a

2023

Volltextzugriff (PDF)

Sickle‐cell disease stroke throughout life: A retrospective study in an adult referral center

American journal of hematology, 2014-03, Vol.89 (3), p.267-272

2014

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(105)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Primary myelofibrosis in untreated sickle cell disease: Are adult patients at higher risk for developing hematological myeloid neoplasms?

Gene Therapy in a Patient with Sickle Cell Disease

Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease

An integrated therapeutic approach to sickle cell disease management beyond infancy

Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene

Lovo‐cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB‐206 study

Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trial

Safety and feasibility of hematopoietic progenitor stem cell collection by mobilization with plerixafor followed by apheresis vs bone marrow harvest in patients with sickle cell disease in the multi‐center HGB‐206 trial

Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion

Sotatercept, a novel transforming growth factor β ligand trap, improves anemia in β-thalassemia: a phase II, open-label, dose-finding study

Proliferating cell nuclear antigen acts as a cytoplasmic platform controlling human neutrophil survival

A novel, highly potent and selective phosphodiesterase-9 inhibitor for the treatment of sickle cell disease

Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome

Ineffective Erythropoiesis in β-Thalassemia

A biomimetic microfluidic chip to study the circulation and mechanical retention of red blood cells in the spleen

Pregnancy outcome in women with transfused beta-thalassemia in France

Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1

Cytoplasmic proliferating cell nuclear antigen connects glycolysis and cell survival in acute myeloid leukemia

Transfusion‐related adverse events are decreased in pregnant women with sickle cell disease by a change in policy from systematic transfusion to prophylactic oxygen therapy at home: A retrospective survey by the international sickle cell disease observatory

Roles of APOL1 G1 and G2 variants in sickle cell disease patients: kidney is the main target

Carboxy-terminal fragment of fibroblast growth factor 23 induces heart hypertrophy in sickle cell disease

Arterio‐venous fistula for automated red blood cells exchange in patients with sickle cell disease: Complications and outcomes

Gene-addition/editing therapy in sickle cell disease

S274: A NEW, EFFECTIVE, SAFE, NON‐MYELOABLATIVE CONDITIONING REGIMEN WITH A HLA‐MATCHED SIBLING DONOR FOR THE SEVERE SICKLE CELL PHENOTYPE IN ADULTS

Sickle‐cell disease stroke throughout life: A retrospective study in an adult referral center

Suchergebnisse filtern